MedPath

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

Phase 3
Active, not recruiting
Conditions
Cardiovascular Diseases
Hypertriglyceridemia
Atherosclerosis
Interventions
Drug: Placebo
Registration Number
NCT05610280
Lead Sponsor
Ionis Pharmaceuticals, Inc.
Brief Summary

The purpose of the study is to evaluate the effect of olezarsen on percent change in fasting triglyceride (TG) levels compared to placebo in participants with hypertriglyceridemia and atherosclerotic cardiovascular disease, or with severe hypertriglyceridemia.

Detailed Description

This is a Phase 3, multi-center, placebo-controlled study in approximately 1475 participants with hypertriglyceridemia and atherosclerotic cardiovascular disease. The study consists of 3 periods: 1) Screening Period: Week -12 to Week -1 (up to 12 weeks); 2) Treatment Period up to Week 53; and 3) Post-Treatment Follow-up Period: Week 54 to Week 66 (13 weeks). Participants enrolled will receive olezarsen or placebo once every 4 weeks during the 53-week Treatment Period.

The Screening Period was extended with no impact to overall study timelines.

A coronary computed tomographic angiography (CTA) sub study will be performed to assess whether triglyceride lowering through inhibition of apoC-III protein synthesis may reduce coronary plaque progression.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
1478
Inclusion Criteria
  • Participants must fall into 1 of the following groups (a or b):

    a. Hypertriglyceridemia with fasting TG ≥200 mg/dL (2.26 millimoles per liter [mmol/L]) and <500 mg/dL (5.65 mmol/L) with either

  • Clinical diagnosis of atherosclerotic cardiovascular disease (ASCVD) or

  • At increased risk for ASCVD

    b. Severe hypertriglyceridemia with fasting TG ≥500 mg/dL (5.65 mmol/L)

  • Participants should be on standard of care (SOC) lipid-lowering medications per local guidelines. Lipid-lowering medications should be optimized and stabilized for at least 4 weeks prior to Screening to minimize changes in these medications during the study.

Exclusion Criteria
  • Hemoglobin A1c (HbA1c) ≥ 9.5% at Screening
  • Alanine aminotransferase or aspartate aminotransferase > 3.0 × upper limit of normal
  • Total bilirubin > 1.5 upper limit of normal unless due to Gilbert's syndrome
  • Estimated GFR < 30 mL/min/1.73 m^2

NOTE: Other Inclusion/Exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboParticipants will be randomized to receive olezarsen-matching placebo, once every 4 weeks by SC injection up to Week 49.
OlezarsenOlezarsenParticipants will be randomized to receive multiple doses of olezarsen, once every 4 weeks by subcutaneous (SC) injection up to Week 49.
Primary Outcome Measures
NameTimeMethod
Percent Change From Baseline to Week 25 in Fasting Triglycerides (TG) Compared to PlaceboBaseline to Week 25
Secondary Outcome Measures
NameTimeMethod
Percent Change From Baseline to Weeks 25 and 53 in Fasting Apolipoprotein B (apoB) Compared to PlaceboBaseline to Weeks 25 and 53
Percent Change From Baseline to Weeks 25 and 53 in Fasting Very Low-Density Lipoprotein-Cholesterol (VLDL)-C Compared to PlaceboBaseline to Weeks 25 and 53
Percent Change From Baseline to Week 53 in Fasting TG Compared to PlaceboBaseline to Week 53
Percent Change From Baseline to Weeks 25 and 53 in Fasting Apolipoprotein C-III (apoC-III) Compared to PlaceboBaseline to Weeks 25 and 53
Proportion of Participants who Achieve Fasting TG <150 Milligrams per Deciliter (mg/dL) at Weeks 25 and 53 Compared to PlaceboBaseline, Weeks 25 and 53
Percent Change From Baseline to Weeks 25 and 53 in Fasting non-High Density Lipoprotein-Cholesterol (HDL)-C Compared to PlaceboBaseline to Weeks 25 and 53
Percent Change From Baseline to Weeks 25 and 53 in Fasting High-Density Lipoprotein-Cholesterol (HDL)-C Compared to PlaceboBaseline to Weeks 25 and 53
Percent Change From Baseline to Weeks 25 and 53 in Fasting Remnant Cholesterol Compared to PlaceboBaseline to Weeks 25 and 53
Percent Change From Baseline to Weeks 25 and 53 in Fasting Low-Density Lipoprotein-Cholesterol (LDL)-C Compared to PlaceboBaseline to Weeks 25 and 53

Trial Locations

Locations (166)

Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore

🇮🇹

Rome, Italy

Universitair Medisch Centrum Utrecht

🇳🇱

Utrecht, Netherlands

FutureMeds Sp. z o.o

🇵🇱

Wrocław, Poland

Slaski Park Technologii Medycznych Kardio-Med Silesia Sp. z o. o

🇵🇱

Zabrze, Poland

Cardio D&R, S.R.O. Kosice

🇸🇰

Kosice, Slovakia

Hospital Clinico Universitario Virgen de la Arrixaca

🇪🇸

El Palmar, Spain

Hospital Clinico San Carlos

🇪🇸

Madrid, Spain

Hospital Universitario Virgen del Rocio

🇪🇸

Sevilla, Spain

Comprehensive Medical & Research Center

🇺🇸

Plantation, Florida, United States

Evanston Premier Healthcare Research LLC

🇺🇸

Evanston, Illinois, United States

Aa Mrc, Llc

🇺🇸

Flint, Michigan, United States

Amicis Research Center

🇺🇸

Valencia, California, United States

Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center

🇺🇸

Torrance, California, United States

Excel Clinical Medical Trials

🇺🇸

Boca Raton, Florida, United States

Aultman Hospital Cardiology Clinical Trials

🇺🇸

Canton, Ohio, United States

Maryland Cardiovascular Specialists

🇺🇸

Baltimore, Maryland, United States

McConnell Heart Health Center

🇺🇸

Columbus, Ohio, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

Juno Research, LLC

🇺🇸

Houston, Texas, United States

Charleston Area Medical Center (CAMC) Clinical Trials Center

🇺🇸

Charleston, West Virginia, United States

Centricity Research - Oshawa Multispecialty

🇨🇦

Oshawa, Ontario, Canada

Centricity Research - Toronto LMC Multispecialty

🇨🇦

Toronto, Ontario, Canada

Finlay Medical Research

🇺🇸

Miami, Florida, United States

Advanced Medical Research Institute (AMRI)

🇺🇸

Miami, Florida, United States

Palm Research Center, Inc.

🇺🇸

Las Vegas, Nevada, United States

SHATC Medica Cor EAD

🇧🇬

Ruse, Bulgaria

D&A Research

🇳🇱

Sneek, Netherlands

Maxima Medisch Centrum

🇳🇱

Veldhoven, Netherlands

FutureMeds - Centrum Medyczne AMED Warszawa Targowek

🇵🇱

Warszawa, Poland

Tennessee Center for Clinical Trials

🇺🇸

Tullahoma, Tennessee, United States

Obudai Egeszsegugyi Centrum

🇭🇺

Budapest, Hungary

MBAL National Cardiology Hospital

🇧🇬

Sofia, Bulgaria

UMHAT Prof. Dr. Stoyan Kirkovich

🇧🇬

Stara Zagora, Bulgaria

Clinexpert Kft.

🇭🇺

Budapest, Hungary

Clinical Research of South Nevada

🇺🇸

Las Vegas, Nevada, United States

Affinity Health Corp.

🇺🇸

Nashville, Tennessee, United States

The Jackson Clinic

🇺🇸

Jackson, Tennessee, United States

Albert Schweitzer Ziekenhuis

🇳🇱

Zwijndrecht, Netherlands

Medical Center for Specialized Medical Help in Cardiovascular Diseases OOD

🇧🇬

Sofia, Bulgaria

Montreal Heart Institute - Institut de Cardiologie de Montreal

🇨🇦

Montreal, Quebec, Canada

Het Van Weel-Bethesda Ziekenhuis

🇳🇱

Dirksland, Netherlands

The Lipid Clinic (Oslo University Hospital)

🇳🇴

Oslo, Norway

Centro Hospitalar Universitario de Lisboa Norte - Hospital de Santa Maria

🇵🇹

Lisboa, Portugal

Alian, s.r.o., Kardiologicka ambulancia

🇸🇰

Bardejov, Slovakia

ARC Biosystems

🇨🇦

Vancouver, British Columbia, Canada

Clinique des Maladies Lipidiques de Quebec Inc.

🇨🇦

Québec, Quebec, Canada

FutureMeds Warszawa Centrum

🇵🇱

Warszawa, Poland

Alabama Clinical Therapeutics, LLC Alabaster

🇺🇸

Birmingham, Alabama, United States

Northern California Research

🇺🇸

Sacramento, California, United States

JSV Clinical Research Study, Inc

🇺🇸

Tampa, Florida, United States

Louisville Metabolic and Atherosclerosis Research Center

🇺🇸

Louisville, Kentucky, United States

Heart Center Research PC

🇺🇸

Huntsville, Alabama, United States

Cardiovascular Research Foundation of Southern California

🇺🇸

Beverly Hills, California, United States

Westside Medical Associates of Los Angeles

🇺🇸

Beverly Hills, California, United States

University of California, San Diego (UCSD)

🇺🇸

La Jolla, California, United States

Diabetes/Lipid Management & Research Center

🇺🇸

Huntington Beach, California, United States

Metabolic Institute of America

🇺🇸

Tarzana, California, United States

Clinical Trials Research

🇺🇸

Lincoln, California, United States

Amicis Research

🇺🇸

Northridge, California, United States

Valley Clinical Trials, Inc.

🇺🇸

Northridge, California, United States

3Sync Research

🇺🇸

Lake Worth, Florida, United States

Finlay Medical Research - West Palm

🇺🇸

Greenacres City, Florida, United States

Global Research Associates

🇺🇸

Homestead, Florida, United States

De La Cruz Research Center, LL

🇺🇸

Miami, Florida, United States

Suncoast Clinical Research, Inc. - New Port Richey

🇺🇸

New Port Richey, Florida, United States

Suncoast Clinical Research, Inc. - Palm Harbor

🇺🇸

New Port Richey, Florida, United States

Proactive Clinical Research

🇺🇸

Oakland Park, Florida, United States

Ocala Cardiovascular Research

🇺🇸

Ocala, Florida, United States

Progressive Medical Research

🇺🇸

Port Orange, Florida, United States

St. Johns Center for Clinical Research

🇺🇸

Saint Augustine, Florida, United States

Centricity Research

🇺🇸

Columbus, Georgia, United States

Atlanta Heart Specialists

🇺🇸

Tucker, Georgia, United States

Clinical Investigation Specialists, Inc

🇺🇸

Gurnee, Illinois, United States

West Broadway Clinic

🇺🇸

Council Bluffs, Iowa, United States

Affinity Health

🇺🇸

Park Ridge, Illinois, United States

Reid Hospital and Health Care Services

🇺🇸

Richmond, Indiana, United States

Cardiovascular Research of Northwest Indiana, LLC

🇺🇸

Munster, Indiana, United States

Mercy One Iowa Heart Center

🇺🇸

West Des Moines, Iowa, United States

Norton Cardiovascular Associates

🇺🇸

Louisville, Kentucky, United States

University of Kansas Medical Center (KUMC)

🇺🇸

Kansas City, Kansas, United States

Summit Research Group, LLC

🇺🇸

Stow, Ohio, United States

Moses H. Cone Memorial Hospital

🇺🇸

Greensboro, North Carolina, United States

Medical University of South Carolina (MUSC)

🇺🇸

Charleston, North Carolina, United States

Green and Seidner Family Practice Associates

🇺🇸

Lansdale, Pennsylvania, United States

Main Street Physicians Care Waterway

🇺🇸

Little River, South Carolina, United States

Central Oklahoma Early Detection Center

🇺🇸

Edmond, Oklahoma, United States

OnSite Clinical Solutions, LLC

🇺🇸

Rock Hill, South Carolina, United States

Monument Health Clinical Research

🇺🇸

Rapid City, South Dakota, United States

Health Concepts

🇺🇸

Rapid City, South Dakota, United States

Texas Institute of Cardiology

🇺🇸

McKinney, Texas, United States

Southern Endocrinology Associates

🇺🇸

Mesquite, Texas, United States

FMC Science

🇺🇸

Round Rock, Texas, United States

Manassas Clinical Research Center

🇺🇸

Manassas, Virginia, United States

Carient Heart & Vascular

🇺🇸

Manassas, Virginia, United States

MHAT Sv. Ivan Rilski - 2003 OOD

🇧🇬

Dupnitsa, Bulgaria

University Multiprofile Hospital for Active Treatment Pulmed OOD

🇧🇬

Plovdiv, Bulgaria

University Multiprofile Hospital for Active Treatment Alexandrovska

🇧🇬

Sofia, Bulgaria

University Multiprofile Hospital for Active Treatment

🇧🇬

Sofia, Bulgaria

Medico Dental Center ISUL Tsaritsa Yoanna EOOD

🇧🇬

Sofia, Bulgaria

Specialized Hospital for Active Treatment of Cardiology

🇧🇬

Varna, Bulgaria

Diagnostic Consultative Center Equita (DCC Equita)

🇧🇬

Varna, Bulgaria

Ecogene-21

🇨🇦

Chicoutimi, Quebec, Canada

Centricity Research - Vaughan Endocrinology

🇨🇦

Concord, Ontario, Canada

Bluewater Clinical Research Group Inc

🇨🇦

Sarnia, Ontario, Canada

Centricity Research - Etobicoke Endocrinology

🇨🇦

Etobicoke, Ontario, Canada

Institute de Recherches Cliniques de Montreal

🇨🇦

Montréal, Quebec, Canada

Centricity Research - Barrie Endocrinology

🇨🇦

Barrie, Canada

Centricity Research - Brampton Endocrinology

🇨🇦

Brampton, Canada

UNIVMED s.r.o. - Kardiologicka Ambulance

🇨🇿

Brno, Czechia

Centre de Recherche Saint-Louis

🇨🇦

Québec, Canada

Cevni ambulance - MATMED s.r.o.

🇨🇿

Hodonin, Czechia

Edumed s.r.o., Kardiologicka, endokrinologicka, diabetologicka a interni ambulance Nachod

🇨🇿

Jaroměř, Czechia

Endokrinologie Cerny Most s.r.o.

🇨🇿

Prague, Czechia

Affidea Praha s.r.o.

🇨🇿

Praha, Czechia

Diabetologicka a endokrinologicka ambulance Milan Kvapil s.r.o

🇨🇿

Praha, Czechia

MUDr. Nina Zemkova s.r.o. Interni Ambulance

🇨🇿

Uherske Hradiste, Czechia

AeskuLab k.s

🇨🇿

Teplice, Czechia

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

Sydvestjysk Hospital

🇩🇰

Esbjerg, Denmark

Gentofte Hospital

🇩🇰

Hellerup, Denmark

Godstrup Regional Hospital (Gødstrup)

🇩🇰

Herning, Denmark

OUH Svendborg Hospital

🇩🇰

Svendborg, Denmark

Viborg Regional Hospital

🇩🇰

Viborg, Denmark

HCL Hopital Louis Pradel

🇫🇷

Bron, France

CHU Dijon Bourgogne - Hopital Francois Mitterrand

🇫🇷

Dijon, France

Groupement de Cooperation Sanitaire (GCS) ELSAN - Polyclinique Vauban

🇫🇷

Valenciennes, France

AP-HP Hopital Pitie-Salpetriere

🇫🇷

Paris, France

CRU Hungary Kft.

🇭🇺

Encs, Hungary

Zuyderland Medisch Centrum

🇳🇱

Heerlen, Netherlands

IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola

🇮🇹

Bologna, Italy

GHM les Portes du Sud

🇫🇷

Vénissieux, France

ASST NORD MILANO-Ospedale Edoardo Bassini

🇮🇹

Cinisello Balsamo, Italy

Azienda Ospedaliero-Universitaria di Ferrara-Arcispedale Sant'Anna

🇮🇹

Cona, Italy

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone

🇮🇹

Palermo, Italy

Centro Cardiologico Monzino

🇮🇹

Milano, Italy

ASST Grande Ospedale Metropolitano Niguarda

🇮🇹

Milano, Italy

Academic Medical Center - Department of Vascular Medicine

🇳🇱

Amsterdam, Netherlands

Ziekenhuis Rijnstate

🇳🇱

Arnhem, Netherlands

Deventer Ziekenhuis

🇳🇱

Deventer, Netherlands

Groene Hart Ziekenhuis

🇳🇱

Gouda, Netherlands

Reinier de Graaf Gasthuis

🇳🇱

Delft, Netherlands

Spaarne Gasthuis

🇳🇱

Haarlem, Netherlands

Bethesda Diabetes Research Center

🇳🇱

Hoogeveen, Netherlands

Canisius-Wilhelmina Ziekenhuis (CWZ)

🇳🇱

Nijmegen, Netherlands

Albert Schweitzer Ziekenhuis - Location Dordrecht

🇳🇱

Zwijndrecht, Netherlands

SALVIA Lekston i Madej s.j.

🇵🇱

Katowice, Poland

Krakowskie Centrum Medyczne Sp. z o.o.

🇵🇱

Krakow, Poland

Jagiellonskie Centrum Innowacji Sp. z o.o.

🇵🇱

Kraków, Poland

Praktyka Lekarska Ewa Krzyzagorska

🇵🇱

Poznań, Poland

Clinical Best Solutions Sp. z.o.o Spolka Komandytowa

🇵🇱

Warsaw, Poland

Narodowy Instytut Kardiologii Stefana kardynala Wyszynskiego - Panstwowy Instytut Badawczy, Klinika Kardiologii i Angiologii Interwencyjnej

🇵🇱

Warsaw, Poland

ETG Zamosc - Pro Life Medica Sp. z o.o

🇵🇱

Zamosc, Poland

FutureMeds

🇵🇱

Łódź, Poland

Centro Hospitalar de Lisboa Ocidental, EPE - Hospital Egas Moniz

🇵🇹

Lisboa, Portugal

INSTYTUT CENTRUM ZDROWIA MATKI POLKI - Klinika Kardiologii i Wad Wrodzonych Doroslych

🇵🇱

Łódź, Poland

Centro Hospitalar de Lisboa Ocidental. E.P.E, - Hospital Santa Cruz

🇵🇹

Carnaxide, Portugal

Centro Hospitalar de Vila Nova de Gaia/Espinho EPE

🇵🇹

Vila Nova de Gaia, Portugal

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

Interna SK, s.r.o., Kardiologicka a interna ambulancia

🇸🇰

Svidnik, Slovakia

Hospital Germans Trias i Pujol

🇪🇸

Badalona, Spain

Diab sro

🇸🇰

Roznava, Slovakia

Hospital Abente y Lago

🇪🇸

La Coruna, Spain

Hospital Universitario Reina Sofia

🇪🇸

Córdoba, Spain

Calle Villarroel 170

🇪🇸

Barcelona, Spain

Hospital Universitario Virgen de la Victoria

🇪🇸

Málaga, Spain

Hospital Universitario Virgen Macarena

🇪🇸

Sevilla, Spain

© Copyright 2025. All Rights Reserved by MedPath